Grantham, Mayo, Van Otterloo & Co (GMO)
BHC icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Bausch Health BHC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-99,700
Closed -$1.54M – 807
2020
Q3 		$1.54M Sell
99,700
-120,900
-55% -$2.08M 0.01% 451
2020
Q2 		$4.02M Sell
220,600
-108,400
-33% -$1.91M 0.03% 274
2020
Q1 		$5.04M Sell
329,000
-1,000
-0.3% -$24.1K 0.04% 242
2019
Q4 		$9.89M Buy
+330,000
New +$8.58M 0.07% 193
2016
Q1 		– Sell
-4,393,848
Closed -$447M – 579
2015
Q4 		$447M Sell
4,393,848
-3,782,738
-46% -$425M 1.61% 18
2015
Q3 		$1.46B Buy
8,176,586
+6,467,840
+379% +$1.51B 5.07% 1
2015
Q2 		$380M Buy
1,708,746
+552,819
+48% +$123M 1.22% 22
2015
Q1 		$230M Buy
1,155,927
+113,736
+11% +$20.2M 0.69% 34
2014
Q4 		$149M Buy
1,042,191
+1,018,486
+4,297% +$137M 0.4% 52
2014
Q3 		$3.11M Sell
23,705
-21,847
-48% -$2.6M 0.01% 318
2014
Q2 		$5.77M Sell
45,552
-107,095
-70% -$13.7M 0.02% 249
2014
Q1 		$20.1M Sell
152,647
-95,427
-38% -$13M 0.05% 152
2013
Q4 		$29.1M Sell
248,074
-36,266
-13% -$3.97M 0.07% 119
2013
Q3 		$29.7M Buy
284,340
+195,411
+220% +$19M 0.08% 109
2013
Q2 		$7.64M Buy
+88,929
New +$7.01M 0.02% 232

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BHC Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Bausch Health (BHC) in Q4 2020, closing a stake of 99,700 shares — an estimated $1.54M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BHC in Q2 2013 and held it in 15 quarters. The position peaked at $1.46B in Q3 2015. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Bausch Health position as of Q4 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 99,700 Bausch Health shares in Q4 2020, an estimated $1.54M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Bausch Health in Q2 2013 and held it in 15 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Bausch Health position peaked at $1.46B in Q3 2015.
  • 338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.